Stocks and Investing Stocks and Investing
Mon, May 20, 2013
Fri, May 17, 2013
Thu, May 16, 2013
Wed, May 15, 2013
Tue, May 14, 2013

David Amsellem Maintained (SUPN) at Buy with Decreased Target to $13 on, May 14th, 2013


Published on 2024-10-25 02:38:30 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Buy with Decreased Target from $14 to $13 on, May 14th, 2013.

David has made no other calls on SUPN in the last 4 months.



There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • David Steinberg of "Jefferies" Initiated at Strong Buy and Held Target at $13 on, Tuesday, March 5th, 2013

Contributing Sources